NEW YORK (GenomeWeb News) – Germany's Indivumed said today that it will conduct clinical research on personalized medicines for cancer in partnership with Georgetown University.

The trials will be conducted at the recently founded Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown.

Since 2007, Hamburg-based Indivumed and Georgetown have collaborated to establish a biobank and clinical database for analyzing tumor specimens to improve cancer diagnostics and to better understand the complex interaction of the cells within a tumor, Indivumed said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.